Twice weekly vindesine, a phase II study in lung cancer
| ISSN: |
1432-1335
|
|---|---|
| Keywords: |
Lung cancer ; Vindesine
|
| Source: |
Springer Online Journal Archives 1860-2000
|
| Topics: |
Medicine
|
| Notes: |
Summary Vindesine 1.75 mg/m2, twice weekly for 2 weeks followed by 2 weeks rest, was given to 26 lung cancer patients. In 6 patients a partial response was seen (23%). Neurotoxicity was present in 15 patients after 1 course; in 6 patients this was the reason for stopping therapy. This regimen has no advantage over weekly vindesine.
|
| Type of Medium: |
Electronic Resource
|
| URL: |